OHR Pharmaceutical
New York
About OHR Pharmaceutical
OHR Pharmaceutical is a development-stage biotechnology company that focuses on the development of products for the treatment of cancer cachexia (multi-symptom wasting disorder) and wet- age-related macular degeneration. It was founded in 2009 and is headquartered in New York, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $47.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Apr 2017)
- Ticker: nasdaq:OHRP
- Website: ohrpharmaceutical.com
- Phone: (212) 682-8452
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ohr-pharmaceutical-2236681 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.